Therapeutic education program to improve life for people after total laryngectomy and their caregivers
Official title: FRENCH THERAPEUTIC EDUCATION PROGRAM AIMING TO IMPROVE LARYNGECTOMIZED PATIENTS' AND THEIR FAMILY CAREGIVER'S QUALITY OF LIFE
Run by University Hospital, Caen · NCT04569500 · Data updated 2026-11-12
This program will see if the PETAL education sessions help adults who had a total laryngectomy and their close relatives improve daily functioning and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 264 (estimated) |
| Sponsor | University Hospital, Caen Academic / other |
| Locations | 1 site (Caen) |
| Status | Recruiting |
| Started | September 24, 2021 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2027 |
| Registry record updated | July 25, 2025 |
| Trial ID | NCT04569500 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) who have undergone total laryngectomy for laryngeal, pharyngeal, or cervical esophageal cancer, can give informed consent, have not had a PTE, and can nominate a willing close relative are ideal candidates.
✕Probably not a fit
Patients with severe physical, psychiatric, or cognitive impairment that prevents participation, or those without an available close relative, are unlikely to benefit from this education program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PETAL program delivers structured therapeutic education to adults who have undergone total laryngectomy and to a close relative or caregiver. Sessions address the physical and functional consequences of laryngectomy (voice loss, swallowing, smell, tracheostomy care) as well as psychosocial and identity-related impacts on patients and families. Participants are enrolled at CHU Caen after informed consent and receive the education intervention with outcomes measured using quality-of-life and caregiver impact instruments. The intervention is non-pharmacologic and aims to build practical skills, coping strategies, and social support for both patients and their close relations.
Why it matters
Potential benefit: If successful, the program could improve patients' daily functioning and emotional well-being while reducing caregiver burden.
How similar studies have gone: Educational and psychosocial programs for head and neck cancer patients and caregivers have shown improvements in quality of life in prior research, though the PETAL program is a novel, locally developed approach in France.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient inclusion criteria * Patients over 18 having been treated by total laryngectomy for cancer of the larynx, pharynx or cervical esophagus. * Patients accepting to participate in the study (informed consent form explained and signed). * Patient having not been undergone a PTE * Person affiliated with an appropriate social security system. Close relation inclusion criteria * Person over 18 designated as being a close relation by the laryngectomized patient (confidential person, spouse, parent, natural support person or any person whose quality of life may be impacted by the patient's laryngectomy). * Close relation accepting to participate in the study (informed consent form explained and signed). * Person authorized by the patient to be contacted by the investigator, in order to propose his/her participation in the research study. * Person affiliated with an appropriate social security system. Patient exclusion criteria - Physical, psychical, psychiatric or cognitive incapacity to answer to questions or participate in interviews/sessions. Close relation exclusion criteria \- Physical, psychical, psychiatric or cognitive incapacity to answer to questions or participate in interviews/sessions.
Where it's running
-
CHU Caen
Caen, France Recruiting
Study contacts
- Study coordinator: Emmanuel PH BABIN
- Email: babin-e@chu-caen.fr
- Phone: +33231064866
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genomic changes of Klebsiella pneumoniae and Enterobacter cloacae in ICU patients over time
This study tests how the gut bacteria Klebsiella pneumoniae and Enterobacter cloacae evolve over time in adults in ICUs.
-
Living with CKD as a woman of childbearing age without dialysis or transplant
This study asks how women aged 18 and up with chronic kidney disease, not on kidney replacement therapy, experience living with the condition.
-
Choosing dialysis: what matters most to patients
This project uses a questionnaire to see which factors, including possible financial compensation, influence dialysis choices among adults with advanced kidney failure who are considering dialysis options.
-
Does GP endorsement and early information improve colonoscopy follow-up after a positive colorectal cancer screening test?
This study tests whether giving patients early information about colonoscopy and having their GP endorse the follow-up can increase how many people in France get a colonoscopy within six months after a positive screening result.
-
How Therapeutic Failure Affects Living with Multiple Sclerosis
This study tests how stopping or changing a DMT due to treatment failure affects quality of life and daily life for adults with relapsing‑remitting MS.
-
Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates
This project will test whether giving primary care doctors and pharmacists extra information about circulating viruses plus a shared protocol helps shorten antibiotic courses for patients with common respiratory infections.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.